Medically reviewed by Drugs.com. Last updated on May 23, 2019.
(GWAHN i deen)
- Guanidine HCl
- Guanidine Hydrochloride
Excipient information presented when available (limited, particularly for generics); consult specific product labeling.
Tablet, Oral, as hydrochloride:
Generic: 125 mg
- Cholinergic Agonist
Use: Labeled Indications
Reduction of the symptoms of muscle weakness associated with the myasthenic syndrome of Eaton-Lambert, not for myasthenia gravis
Hypersensitivity to guanidine or any component of the formulation
Eaton-Lambert syndrome: Oral: Initial: 10-15 mg/kg/day in 3-4 divided doses, gradually increase to 35 mg/kg/day, or up to development of side effects
Refer to adult dosing.
Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).
Acetylcholinesterase Inhibitors: May enhance the adverse/toxic effect of Cholinergic Agonists. Monitor therapy
Beta-Blockers: May enhance the adverse/toxic effect of Cholinergic Agonists. Of particular concern are the potential for cardiac conduction abnormalities and bronchoconstriction. Management: Administer these agents in combination with caution, and monitor for conduction disturbances. Avoid methacholine with any beta blocker due to the potential for additive bronchoconstriction. Monitor therapy
Cimetropium: Cholinergic Agonists may diminish the anticholinergic effect of Cimetropium. Monitor therapy
Sincalide: Drugs that Affect Gallbladder Function may diminish the therapeutic effect of Sincalide. Management: Consider discontinuing drugs that may affect gallbladder motility prior to the use of sincalide to stimulate gallbladder contraction. Consider therapy modification
Frequency not defined.
Cardiovascular: Atrial fibrillation, cold extremities, flushing, hypotension, palpitations, tachycardia
Central nervous system: Ataxia, confusion, dizziness, emotional lability, hallucination, irritability, jitteriness, mood changes, nervousness, psychosis
Dermatologic: Diaphoresis, folliculitis, paresthesia, skin rash, xeroderma
Gastrointestinal: Abdominal cramps, anorexia, diarrhea, gastric irritation, nausea, sore throat, xerostomia
Hematologic & oncologic: Anemia, bone-marrow depression, bruise, leukopenia, petechia, purpura, thrombocytopenia
Hepatic: Abnormal hepatic function tests
Neuromuscular & skeletal: Tremor
Renal: Increased serum creatinine, interstitial nephritis (acute or chronic), renal tubular necrosis
Concerns related to adverse effects:
• Bone marrow suppression: Dose-related, fatal bone marrow suppression had been reported with use. Avoid concurrent use with medications known to suppress bone marrow. Monitor closely; discontinue use if bone marrow suppression is suspected.
• Renal impairment: Use with caution in patients with renal impairment.
CBC with differential (baseline and frequently thereafter); renal function (creatinine, BUN) and urinalysis (regularly)
Animal reproduction studies have not been conducted.
• Discuss specific use of drug and side effects with patient as it relates to treatment. (HCAHPS: During this hospital stay, were you given any medicine that you had not taken before? Before giving you any new medicine, how often did hospital staff tell you what the medicine was for? How often did hospital staff describe possible side effects in a way you could understand?)
• Patient may experience abdominal pain, flushing, sweating a lot, lack of appetite, nausea, diarrhea, abdominal cramps, or dry mouth. Have patient report immediately to prescriber signs of infection, signs of bleeding (vomiting blood or vomit that looks like coffee grounds; coughing up blood; hematuria; black, red, or tarry stools; bleeding from the gums; abnormal vaginal bleeding; bruises without a reason or that get bigger; or any severe or persistent bleeding), signs of kidney problems (urinary retention, hematuria, change in amount of urine passed, or weight gain), severe loss of strength and energy, behavioral changes, severe dizziness, passing out, burning or numbness feeling, cold sensation in arms or legs, anxiety, change in balance, tremors, confusion, mood changes, hallucinations, abnormal heartbeat, skin changes, or tachycardia (HCAHPS).
• Educate patient about signs of a significant reaction (eg, wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat). Note: This is not a comprehensive list of all side effects. Patient should consult prescriber for additional questions.
Intended Use and Disclaimer: Should not be printed and given to patients. This information is intended to serve as a concise initial reference for healthcare professionals to use when discussing medications with a patient. You must ultimately rely on your own discretion, experience and judgment in diagnosing, treating and advising patients.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.